Sage Therapeutics (SAGE)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

About Sage Therapeutics (SAGE)

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenou... Read more

Open
USD50.04
High
USD50.24
Low
USD48.75
52 Week High
USD54.86
Monthly Return
1.30%
Revenue
9M

Daily Vol.
133.83k
Avg. Daily Vol.
455.33k
Market Cap.
3.0B
52 Week Low
30.67
Annual Return
58.30%

Stock News

1 hour ago

Buy Buy Baby draws sale interest in Bed Bath & Beyond bankruptcy, one bidder looks to save stores

CNBC

1 hour ago

Brett Arends's ROI: Americans are ‘more afraid of running out of money than death’

MarketWatch

1 hour ago

: Target’s stock snaps longest losing streak in 23 years as anti-LGBTQ+ backlash continues

MarketWatch

1 hour ago

Hourly Pay for US Shale Workers Tops $43, a Record in the Industry’s Hunt for Employees

Yahoo

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Get The App

Build Your Long Term Wealth

A modern investment app with fair pricing.

Get the App

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Explore

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Get Premium